Lesley Portnoy and Nektar Therapeutics

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nektar Therapeutics | Globe Newswire | 10/9/2019

Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR ) investors who purchased securities between February 15, 2019 and August 8, 2019 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire …

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nektar Therapeutics - GuruFocus.com | 10/9/2019

Nektar Therapeutics (“Nektar” or the “Company”) ( NKTR ) investors who purchased securities between February 15, 2019 and August 8, 2019 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, at …

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nektar Therapeutics | Benzinga | 10/2/2019

Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR ) investors who purchased securities between February 15, 2019 and August 8, 2019 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire …

Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Nektar Therapeutics | Financial Buzz | 9/20/2019

Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR ) investors who purchased securities between February 15, 2019 and August 8, 2019 , inclusive (the “Class Period”). If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire …

Glancy Prongay & Murray LLP Announces Investigation on Behalf of Nektar Therapeutics Investors – Company Announcement - FT.com | Financial Times | 8/10/2019

Nektar Therapeutics (“Nektar” or the “Company”) (NASDAQ: NKTR ) investors concerning the Company and its officers’ possible violations of federal securities laws. If you are a shareholder who suffered a loss, click here to participate. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire , at 310-201-9150, Toll …